Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period

NCT04008784 · clinicaltrials.gov ↗

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Crisaborole 2% Topical Application Ointment [EUCRISA]
DRUG: Triamcinolone Acetonide 0.1% Ointment

Sponsor

Clinical Research Center of the Carolinas

Collaborators

[object Object]